The first patient to receive the ExoVasc® Personalised External Aortic Root Support – inventor Tal Golesworthy – has now reached the four and a half year anniversary of receiving the implant that pioneered the procedure.
A recent MRI scan confirmed the findings in all of the patients in the trial to date: the implant appears to halt any further increase in the diameter of the ascending aorta.
“I am delighted to read the stories posted by more recent patients who have received the implant.” says Tal. He adds, “It is good to see others sharing the relief from worrying about the future and not having the drawbacks associated with anticoagulant therapy. I look forward to my fifth birthday and many more thereafter!”